Mad Money

Cramer's lightning round: Stick with this 'terrific' defense play

Share

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Pfizer: "Well, Pfizer's kind of sitting there. They need to do a deal, they need to split up or buy someone. They should buy Bristol-Myers [Squibb]. Then we'd have everything work out."

Arconic Inc.: "Well, we're telling club members of [Cramer's charitable trust] ActionAlertsPlus.com that as we get closer to [the vote on the company's director nominees], we will make a decision. We do like the fact that Klaus Kleinfeld split the company up and created a lot of value, though."

Intrexon Corp.: "This is the ultimate speculative stock. They either are going to solve the world's problems or they're not, and I think you have to recognize when you buy the spec stocks, $19 to $27 means nothing. Because it's either going to go to $50 or it's going to go to $9. So my take is, you're in it, stick with it."

Raytheon Company: "Oh, man, Raytheon is terrific. It's held up better than all the other defense contractors that I follow. I think it's a great stock. You want to continue to own it."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com